참고문헌 (27)

1. Hu B, Guo H, Zhou P, Shi Z-L, "Characteristics of？SARS-COV-2 and COVID-19," Nat Rev Microbiol.,？United Kingdom, pp. 141-154, 2021. 

2. She J, Jiang J, Ye L, Hu L, Bai C, Song Y, "2019？novel coronavirus of pneumonia in Wuhan, China:？Emerging attack and management strategies," Clin？Transl Med., United States, p. 19, 2020. 

3. Mohan BS, Vinod N, "Covid-19: An insight into？SARS-cov2 pandemic originated at Wuhan City in？Hubei Province of China," J Infect Dis Epidemiol.,？United States, p. 146, 2020. 

4. Vivier E, Tomasello E, Baratin M, Walzer T,？Ugolini S, "Functions of Natural Killer Cells," Nat？Immunol., United Kingdom, pp. 503-10, 2008. 

5. Lee AJ, Kim SG, Jeon CH, Suh HS, Yoon GS, Seo？AN, "A case of natural killer cell leukemia？misdiagnosed as tuberculous lymphadenopathy,"？Korean J Lab Med., Korea, pp. 194-198, 2009. 

6. Anguille S, Van Acker HH, Van den Bergh J,？Willemen Y, Goossens H, Van Tendeloo VF, Smits？EL, Berneman ZN, Lion E, "Interleukin-15 Dendritic？Cells Harness NK Cell Cytotoxic Effector Function？in a Contact- and IL-15-Dependent Manner," PLoS？One., United States, e0123340, 2015. 

7. Carrillo-Bustamante P, Kesmir C, de Boer RJ, "The？evolution of natural killer cell receptors,"？Immunogenetics., Germany, pp. 3-18, 2016. 

8. Kapur R, Evans DL, Harris DT, "An evolutionary？conserved target cell antigen along with MHC class？I molecules influences susceptibility to murine NK？cell lysis," Dev Comp Immunol., United Kingdom,？pp. 347-55, 1995. 

9. Kumar S, "Natural killer cell cytotoxicity and its？regulation by inhibitory receptors," Immunology.,？United Kingdom, pp. 383-393, 2018. 

10. Bjorkstrom NK, Strunz B, Ljunggren HG, "Natural？killer cells in antiviral immunity," Nat Rev？Immunol., United Kingdom, pp. 112-123, 2022. 

11. Orr MT, Lanier LL, "Natural killer cell education？and tolerance," Cell., United States, pp. 847-856,？2010. 

12. Zwirner NW, Ziblat A, "Regulation of NK Cell？Activation and Effector Functions by the IL-12？Family of Cytokines: The Case of IL-27," Front？Immunol., Switzerland, 8:25, 2017. 

13. Mah AY, Cooper MA, "Metabolic Regulation of？Natural Killer Cell IFN-γ Production," Crit Rev？Immunol., United States, pp. 131-147, 2016. 

14. Somanchi SS, Senyukov VV, Denman CJ, Lee DA,？"Expansion, purification, and functional assessment？of human peripheral blood NK cells," J Vis Exp.,？United States, p. 2540, 2011. 

15. Nakazawa T, Morimoto T, Maeoka R, Matsuda R,？Nakamura M, Nishimura F, Yamada S, Nakagawa？I, Park YS, Nakase H, Tsujimura T, "Establishment？of an efficient ex vivo expansion strategy for human？natural killer cells stimulated by defined cytokine？cocktail and antibodies against natural killer cell？activating receptors," Regen Ther., Japan, pp. 185-191, 2022. 

16. Tanaka Y, Nakazawa T, Nakamura M, Nishimura？F, Matsuda R, Omoto K, Shida Y, Murakami T,？Nakagawa I, Motoyama Y, Morita H, Tsujimura T,？Nakase H, "Ex vivo-expanded highly purified？natural killer cells in combination with temozolomide？induce antitumor effects in human glioblastoma？cells in vitro," PLoS One., United States, e0212455,？2019. 

17. Min B, Choi H, Her JH, Jung MY, Kim H-J, Jung？M-young, et al., "Optimization of large-scale？expansion and cryopreservation of human natural？killer cells for anti-tumor therapy," Immune？Network, South Korea, e31, 2018. 

18. Bae DS, Lee JK, "Development of NK cell？expansion methods using feeder cells from human？myelogenous leukemia cell line," Blood Res., South？Korea, pp. 154-61, 2014. 

19. Zafarani A, Razizadeh MH, Pashangzadeh S,？Amirzarga MRr, Taghavi-Farahabadi M, Mahmoudi？M, "Natural killer cells in COVID-19: from infection,？to vaccination and therapy," Future Virol., England,？2023. 

20. Kim H, Byun JE, Yoon SR, Koohy H, Jung H,？Choi I, "SARS-CoV-2 peptides bind to NKG2D？and increase NK cell activity," Cell Immunol.,？United States, 104454, 2022. 

21. Di Vito C, Calcaterra F, Coianiz N, Terzoli S,？Voza A, Mikulak J, Della Bella S, Mavilio D,？"Natural Killer Cells in SARS-CoV-2 Infection:？Pathophysiology and Therapeutic Implications,"？Front Immunol., Switzerland, 888248, 2022. 

22. Capuano C, Pighi C, Battella S, De Federicis D,？Galandrini R, Palmieri G, Harnessing Cd16-Mediated Nk Cell Functions to Enhance Therapeutic？Efficacy of Tumor-Targeting Mabs. Cancers(Basel),？Switzerland, 2021. 

23. Pituch-Noworolska AM, "NK cells in SARS-CoV-2？infection," Cent Eur J Immunol., Poland, pp. 95-101, 2022. 

24. Wiley SR, Schooley K, Smolak PJ, Din WS,？Huang CP, Nicholl JK, et al., Identification and？Characterization of a New Member of the Tnf？Family That Induces Apoptosis. Immunity, United？States, pp. 673-682, 1995. 

25. Bjorkstrom NK, Riese P, Heuts F, Andersson S,？Fauriat C, Ivarsson MA, Bjorklund AT, Tullberg？MF, Michaelsson J, Rottenberg ME, Guzman CA,？Ljunggren HG, Malmberg KJ, Expression patterns？of NKG2A, KIR, and CD57 define a process of？CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood, United States, pp. 3853-3864, 2010. 

26. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky？AS, "Angiotensin-converting enzyme 2 (ACE2) as a？SARS-CoV-2 receptor: molecular mechanisms and？ potential therapeutic target," Intensive Care Med.,？United States, pp. 586-590, 2020. 

27. Deng X, Terunuma H, Nieda M, "Exploring the？Utility of NK Cells in COVID-19," Biomedicines.,？Switzerland, 1002, 2022. 

저자의 다른 논문 :

윤형석 (4) 유치호 (5) 구세훈 (4) 이용한 (8) 허경행 (13)

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.